Glenmark Pharma
Glenmark Pharma
Key Stats (Trailing)
52W Range
₹ 767 - 1831
MCap
₹ 43484 Cr
Volume
12 k
Div. Yield
0.3 %
Dividend
₹ 2.5
EPS
₹ -53.2
CEPS
₹ -44.3
PE Ratio
0
PEG
-0
P/CE
-21.6
EV/Net Sales
2.2
EV/EBITDA
13
EV/CE
3
P/S
2.3
P/B
3.5
Book NAV/Share
₹ 277.5
Sales Growth
2 %
EBITDA Growth
5.8 %
EBIT Growth
-6.2 %
PAT Growth
-1944.3 %
EPS Growth
-605.2 %
ROA
-11.9 %
ROE
-21.2 %
ROCE
4.9 %
D/E
0.1
Current Ratio
1.3
Quick Ration
0.8
Interest Cover
1.1
EBITDA Margin
4.3 %
Pre-tax Margin
0.1 %
PAT Margin
-6.6 %
Tax Rate
5116.7 %
Cash Profit Margin
-4.5 %
Asset Turnover
1.8
Sales/Fixed Asset
2.8
Working Capital/Sales
17.2
Receivable Days
37
Payable Days
191
Inventory Days
33
Revenue
in ₹ Crores
EPS
in ₹
Margin
Annual P&L
in Crores
Revenue (TTM)
12,248
Operating Profit (TTM)
2,376
PAT (TTM)
-994
EPS (in Rs.) (TTM)
-31
Balance Sheet
in Crores
Cash & Bank Balance (2024)
1,660
Inventories (2024)
2,513
Total Debt (2024)
991
Adjusted Book Value (in Rs.) (2024)
278
Cash Flow
in Crores
CF Operating Activities(2024)
-265
CF Investing Activities (2024)
4,561
CF Financing Activities (2024)
-3,906
Net Cash Flow (2024)
389
Valuation
P/E (2024)
0.0
P/B (2024)
3.5
EV/Sales (2024)
2.2
EV/EBITDA (2024)
13.0
Shareholding
Growth
Net Sales (2024)
2 %
Core EBITDA (2024)
6 %
PAT (2024)
-1,944 %
EPS (2024)
-605 %
Performance
ROA (2024)
-11 %
ROE (2024)
-21 %
ROCE (2024)
5 %
Asset Turnover (2024)
1.8
Financial Stability
Total Debt / Equity (2024)
0.1
Current Ratio (2024)
1.3
Quick Ratio (2024)
0.8
Interest Cover (2024)
1.1
Peers
by Market Cap in ₹ Crores
DCF Value
Reverse DCF
No related articles found !!!